THE EXPRESSION ANALYSIS OF SPECIFIC GENES IN OVARIAN CANCER-Reference-Cited by-同舟云学术

THE EXPRESSION ANALYSIS OF SPECIFIC GENES IN OVARIAN CANCER

Published:2023-10-31 Issue:Kongre Özel Sayısı Volume:2 Page:136-143
ISSN:2822-6445
Container-title:Doğu Karadeniz Sağlık Bilimleri Dergisi
language:
Short-container-title:

Author:

GÜMÜŞOĞLU-ACAR Ece¹^ORCID,DOĞAN Berkcan²^ORCID,BİLİR Mehmet Ulaş¹^ORCID,SENTURK-KİRMİZİTAS Tugce¹^ORCID,TOPUZ Samet³^ORCID,GUNEL Tuba¹^ORCID

Affiliation:

1. ISTANBUL UNIVERSITY, FACULTY OF SCIENCE, DEPARTMENT OF MOLECULAR BIOLOGY AND GENETICS, MOLECULAR BIOLOGY AND GENETICS PR.

2. BURSA ULUDAG UNIVERSITY

3. ISTANBUL UNIVERSITY, İSTANBUL FACULTY OF MEDICINE, İSTANBUL MEDICINE PR.

Abstract

Aim: Ovarian cancer (OC) is the most lethal gynecologic malignancy and frequently diagnosed at an advanced stage because of the inadequate number of biomarkers. Therefore, identification of OC specific biological markers is a vital step for diagnosis and treatment response. Our goal is to examine functional gene sets which are possibly markers for ovarian cancer and their expression profiles in OC patients. We also aim to determine the potential genes for therapeutic targets for OC patients. Method: The expression levels of seven genes (FOS, FOSL2, JUN, MMP-2, MMP-9, TIMP-2, and VEGFA) were identified by qRT-PCR. The tumor-free control group consisted of total abdominal hysterectomy (n=1) and bilateral salpingo-oophorectomy (n=9) patients who underwent gynecologic procedures. High-grade serous OC epithelial samples (n=10) were used for the experiment group. Results and Conclusions: According to the qRT-PCR data, there is an increased expression of FOS (p=0.0089), MMP-9 (p=0.0029), VEGFA (p=0.0434) and decreased expression of FOSL2 (p=0.0271), JUN (p=0.0041), TIMP-2 (p=0.0062). In conclusion, the results can indicate the new perspective for OC pathogenesis and treatment. For future studies, these genes can be used in personalized diagnosis and therapy of OC.

Publisher

Giresun Üniversitesi

Reference24 articles.

1. Alshamrani A. A. (2020). Roles of microRNAs in Ovarian Cancer Tumorigenesis: Two Decades Later, What Have We Learned?. Frontiers in oncology, 10, 1084.

2. Apostolou, P., Iliopoulos, A. C., Parsonidis, P., & Papasotiriou, I. (2019). Gene expression profiling as a potential predictor between normal and cancer samples in gastrointestinal carcinoma. Oncotarget, 10(36), 3328–3338.

3. Bejjani, Fabienne, et al. "The AP-1 transcriptional complex: Local switch or remote command?." Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1872.1 (2019): 11-23.

4. Escalona, R.M., Bilandzic, M., Western, P. et al. TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells. BMC Cancer 20, 960 (2020). https://doi.org/10.1186/s12885-020-07274-6.

5. Gumusoglu-Acar, E., Gunel, T., Hosseını, M. K., Dogan, B., Tekarslan, E. E., Gurdamar, B., Cevık, N., Sezerman, U., Topuz, S., Aydınlı, K. (2023). Metabolic pathways of potential miRNA biomarkers derived from liquid biopsy in epithelial ovarian cancer. Oncology Letters, 25(4), 142.